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Abstract 
Peritoneal Carcinomatosis (PC) is one of the final stages of abdominal cancers. Nowadays Cytoreductive Surgery followed by 
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) proves to be a promising therapeutic solution. The authors are developing 
an HIPEC equipment and this paper presents an advanced cytostatic solution temperature control structure. A cascade plus feed-
forward control structure is proposed in order to compensate the major temperature disturbances: the temperature loss due to the 
heat exchange between the solution and the environment, and the heat exchange between the cytostatic solution circulated inside 
the abdominal cavity and the human body. The assessment of the results is made via computer simulation. 
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1. Introduction 
Peritoneal Carcinomatosis (PC), one of the final stages of abdominal cancers, is associated with an unfavorable 
clinical evolution of the patients1,2. For a long time (since 1931, when Sampson3 described PC in an ovarian cancer 
patient), treatment was mostly palliative and thus, PC was linked to “terminal status/despair”. Despite the 
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progressive development of systemic chemotherapy, in a population-based study4, Leemens confirmed the poor 
median survival in PC patients, unlike that of patients with hepatic metastases. Also, the median survival of PC 
metastasis patient was unchanged by various chemotherapy regimens5. Nowadays Cytoreductive Surgery followed 
by Hyperthermic Intraperitoneal Chemotherapy (HIPEC) proves to be a promising therapeutic solution for selected 
patients suffering from PC6–8. 
HIPEC requires the spread of cytostatic drugs during the surgical intervention at high temperatures (41-43˚C), by 
means of specific devices, within 60 to 120 minutes. The most used device for HIPEC, in clinical practice, was 
Spratt model device9, whose basic architecture being represented by a supply pump, a heat exchanger, temperature 
sensors (between two and four), flow sensors, and a tank for the cytostatic solution (Fig. 1a). Cytostatic solution 
inflow was assessed by two channels and outflow, usually, by three. There are a number of commercially available 
equipment’s, such as ThermoChem HT-2000 (www.thermasolutions.com), Cavitherm (www.cavitherm.com), 
SUNCHIP (www.gamidatech.com), Belmont Hyperthermia Pump (www.belmontinstrument.com), but, despite their 
high cost, they have some shortcomings such as: lack of temperature monitoring in multiple points of the solution 
circulated through the peritoneal cavity for providing comprehensive information; the absence of solution 
distribution through multiple channels, which favor the appearance of areas that have a lower temperature than that 
required; the lack of advanced control systems implemented in order to obtain a uniform temperature in the 
peritoneal cavity. 
This paper introduces an advanced temperature control structure for the cytostatic solution, considering the 
temperature disturbances that can occur in the system. The major disturbances are the heat exchange between the 
solution and the environment during the solution’s delivery to the patient, and the heat exchange between the 
solution circulated inside the abdominal cavity and the human body. 
For the rejection of the disturbances the authors propose a cascade control structure in respect to the initial 
disturbance and a feed-forward control structure in relation to the second disturbance mentioned above. The cascade 
control implies the existence of an inner control loop for the temperature at the output of the heater and an outer 
control loop for the temperature inside the peritoneal cavity. The feed-forward control structure implies the existence 
of a measurable disturbance10, in this case the human body temperature. The analysis and validation of the proposed 
control structures is made via computer simulation. 
This paper is organized as follows: in section 2 we present the proposed HIPEC device architecture, in section 3 
the advanced temperature control structure, and in section 4 we present the simulation results. 
2. The HIPEC device architecture 
The authors are developing innovative HIPEC equipment that will bring some improvements over current ones. 
The main components of the developed HIPEC device architecture are a tank (used to store and preheat the 
cytostatic solution at a temperature of 38˚C); supply and return pumps11; up to eight delivery channels for a better 
distribution of the cytostatic drugs solution into the patient’s intraperitoneal cavity; temperature sensors used for 
monitoring the temperature of the solution in multiple points, in order to provide comprehensive information 
regarding the intraperitoneal temperature distribution (see Fig. 1b)12,13. 
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a)  b)  
Fig. 1. (a) HIPEC Sprat model devices architecture. (b) The developed HIPEC device architecture, according to14. 
Each solution delivery channel will be independent and will be composed of plastic tubes, a heater, individual 
heat controller and temperature sensors. The heating controller is mandatory in order to ensure the delivery of the 
solution at the desired temperature (41-43˚C). Sustaining rigorous temperature range ensures cytostatic drugs 
potentiating 15,16 and prevents risk of thermal injuries occurrence, so it represents a key condition for ensuring the 
effectiveness of treatment. 
The heater is built as a heating resistance constructed as windings on the exterior wall of a cylindrical tube, 
through which the solution is circulated, working as a heat exchanger. The heater’s transfer function model (HHS) is 
determined using Strejc fitting method17,based on an experimentally determined step response, and it is presented in 
equation (1).The electric power of the heating resistance is applied using Pulse-width modulation (PWM). The 
PWM transfer function has a gain equal to 30. The solution temperature at the output of the heater is measured using 
a PT 1000 temperature sensor (T1), and it is applied at the input of the peritoneal cavity. The temperature 
transducer’s transfer function is given in (2) and the corresponding gain is computed in (3). 
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where KT1 represents the transducer’s gain and TT1 represents the transducer’s time constant. 
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where imin, imax represent the domain limits of the unified current signal generated by the transducer, and T represents 
the measured signal variations, obtained from a sample of experimental study measurements given in Table 1, for a 
chosen period of 35 minutes. In order to prevent higher temperatures for the human body the cytostatic solution 
reference temperature is going to be set at 42˚C. 
Table 1.Temperature (T) measurements of the cytostatic solution. 
Time 
[h.min] 
T at the input of the peritoneal 
cavity [˚C] 
T inside the peritoneal 
cavity [˚C] 
Core temperature of the 
human body[˚C] 
15.0 42.1 38.6 35.6 
15.5 42.1 38.8 35.8 
15.10 42.9 39.8 36 
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15.15 41.8 40.1 37 
15.20 43.7 41.3 38.3 
15.25 43.1 42.2 39 
15.30 42.9 42.8 39.2 
15.35 42.8 42.6 39.4 
 
The connection between the temperature of the solution at the input in the peritoneal cavity and the temperature 
of the solution in the peritoneal cavity, measured using a temperature transducer (T2), is made using the process 
described by the following transfer function18. 
2
2
2
0.9( )
1 20 1
     
SP
HS
SP
KH s
T s s
   (4) 
The transfer function of the temperature measurement transducer (HT2) is presented in (5) where TT2 represents 
the time constant, TD represents the time delay, and KT2 represents the gain:  
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3. Temperature control structure 
The advanced control structure, which contains both the cascade control and the feed-forward control, proposed 
for the cytostatic solution temperature control is presented in Fig. 2,where w represents the unified current reference 
signal, e1, e2 represent the error signals, c1, c2, c4 represent the control signals and d1, d2 represent the disturbance 
signals. All other signals and blocks notations will be described in what follows. 
3.1. Cascade control structure 
The use of this structure is possible if a complex process can be split into two or more sub-processes, and the 
connection between them is accomplished by means of intermediate measurable signals19. For the HIPEC 
equipment: the first sub-process makes the connection between the PWM that applies the electrical power for the 
heating source and the temperature of the solution at the input in the peritoneal cavity (HHS); the second sub-process 
makes the connection between the temperature of the solution at the input in the peritoneal cavity and the 
temperature of the solution inside the peritoneal cavity (HHS2) (see Fig. 2). 
The influence of the d1 disturbance (the heat exchange between the solution and the environment) is notable on 
the temperature at the input of the peritoneal cavity. Thus, the cascade control consists of two control loops: the 
faster inner loop with respect to the temperature at the input of the peritoneal cavity (y1) and the outer loop with 
respect to the temperature inside the peritoneal cavity (y). 
The inner loop ensures the control of the cytostatic solution temperature at the output of the heater, which is the 
temperature at which the solution is delivered into the peritoneal cavity. The inner loop controller (C1) is designed 
using the Modulus design method20. The direct path transfer function is presented in (6), where TƩ represents the sum 
of all parasitic process time constants21,22 (the sum of the fast time constants obtained from the actuator). The 
feasible controller’s transfer function is obtained using the formula presented in (7). The second order filter’s time 
constant is equal to the sum of all parasitic process time constants. 
_
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The outer loop ensures the control of the solution temperature inside the peritoneal cavity. The outer loop 
controller (C2) is designed using the Ziegler-Nichols design method. This method consists in adding a proportional 
controller in a feed back control structure with the process to be controlled.  
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Fig. 2. The advanced cytostatic solution temperature control structure. 
The controller’s gain is increased until the controlled process reaches the stability limit23,24. The gain value that 
generates the critically damped temperature signal represents the critical gain (kcritical). The critical period of 
oscillations (Tcritical) is read from the oscillating step response plot. The PI or PID controller’s parameters are 
determined using the formulae presented in Table 2. The transfer function of a feasible PID controller is shown in 
(8), where kCZN is the controller’s gain, TIZN is the integrative time constant, TDZN is the derivative time constant and 
the filter’s time constant (Tf) is ten times smaller than the derivative time constant. 
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Table 2. Ziegler-Nichols PI and PID controller parameters design table20. 
Controller 
type 
Controller gain 
kCZN 
Integrative time 
constant TIZN 
Derivative time 
constant TDZN 
PI 0.45 criticalk  0.8 criticalT  0  
PID 0.75 criticalk  0.6 criticalT  0.1 criticalT  
3.2. Feed-forward control structure 
The control law based on the disturbance compensation (feed-forward) can be implemented only if the 
disturbance can be measured (in which case it is possible to introduce an additional feedback in respect with the 
disturbance12 (see Fig. 2). For the control of the cytostatic solution temperature the d2 disturbance represents the heat 
exchange between the solution circulated inside the abdominal cavity and the core temperature of the human body 
that is measured using a T3 temperature transducer, having the transfer function presented in (5). 
The notion of disturbance compensation relates to generating a control signal in such a way that it acts 
simultaneously and in opposite direction with the disturbance effect, using a compensation block (CB)19. From Fig. 
2 it results that c3=c2-c4, meaning that the control signal generated by the C2 controller is "adjusted" with the c4 
signal’s corresponding value, thus, forcing the disturbance compensation. Since the c4 control signal is applied with 
a negative sign, the compensation effect works in the opposite direction of the disturbance effect. 
The compensation block is computed in such a way that the signal y’ will be equal to the disturbance d2 (c2 = 0). 
In order to compute the compensation block transfer function the transducer’s time delay and the inner loop transfer 
function are neglected, since the sub-process is much faster. In order to obtain a feasible controller, a second order 
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filter (HF) is added having a time constant equal to 1 second and the transfer function presented in (9) results for the 
compensation block.  
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4. Simulation results 
The control structures described in previous sections are compared based on their simulated step response signals. 
The control structures are implemented using Matlab.Simulink®. The solution temperature control is performed on 
the preheated solution of 38˚C, thus, this value corresponds in simulation to the 0˚C value. The reference signals are 
in unified currents (4-20 mA) and are set at 8 mA for all the control structures. 
The inner loop from the cascade control is simulated using the PWM transfer function equal to 30, the heating 
system’s model from (1), the transducer transfer function from (2) and the inner loop controller transfer function 
given in (7). The simulated step response is presented in Fig. 3. It can be noted that, due to the second order filter, no 
overshoot is obtained and the settling time is about 109 seconds. 
 
Fig. 3. The inner loop simulated step response. 
The outer loop controller HC2 is tuned using the Ziegler-Nichols method. In order to prove the advantages of 
cascade control the controller is first tuned without the inner loop control, considering a classic control structure for 
the control of the temperature inside the peritoneal cavity. On the direct path we consider only the PWM block and 
the two sub-processes. The critical gain is obtained as 2.87687. The critical period of oscillations is determined as 
126 seconds from the critically damped step response plotted in Fig. 4a, considering the time between the maximum 
of two adjacent oscillations. Using the formulae from Table 2 the (10) PI and PID controller are obtained. The 
corresponding step responses obtained when using the two controllers are presented in Fig. 4b, and it results that the 
PI controller generates the best performances set (overshoot of 14.7%, settling time of 370 seconds) since the two 
control structures generate similar settling times but the overshoot obtained for the PI control structure is much 
smaller. The PI controller is chosen for the classical control structure. 
Second, the outer loop HC2 controller is tuned using the Ziegler-Nichols method and the cascade control structure 
presented in Fig. 2. The critical gain for this case is 3.9378 and the critical period of oscillations is determined as 
19.48 seconds (see Fig. 5a). From the previous comparison between the PI and the PID controller obtained using the 
Ziegler-Nichols method it resulted that the PI controller generated better performances, thus, for the cascade outer 
loop controller only the PI controller is determined. The controller’s gain was adjusted in order to obtain better 
results (overshoot of 0.38% and settling time of 103 seconds) and the controller transfer function is given in (11). 
The comparison between the classical control structure and the cascade control structure is made based on their 
simulated step responses. A -0.8˚C d1 disturbance was added at a time equal to 500 seconds, for both control 
structures. The disturbance effect is much better compensated by the cascade control structure (see Fig. 5b). 
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Fig. 4. (a) The critically damped step response obtained for the classic control of the solution temperature inside the peritoneal cavity; (b) The 
comparison between the PI and PID controller for the classical control structure. 
a) b)  
Fig. 5. (a) The critically damped step response obtained for the cascade outer loop control; (b) The comparison between the classical control 
structure and the cascade control structure. 
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The feed-forward control is added to the cascade control structure (see Fig. 2) and the disturbance compensation 
is analyzed in Fig. 6 by plotting the cascade control structure and the cascade plus feed-forward control structure 
step responses.  A d1 step disturbance of -1˚C is added at a time equal to 400 seconds and a d2 step disturbance of -
2˚C (meaning that the core temperature of the human body decreases with 2˚C) is applied at a time equal to 700 
seconds. When adding the feed-forward into the control structure the effect of the d2 disturbance is strongly 
decreased. 
5. Conclusions 
This paper demonstrates the advantages of using an advanced control structure for the cytostatic drugs solution 
temperature control of both used and proposed by authors HIPEC equipment. The proposed control structure is a 
cascade plus feed-forward control designed to compensate the effect of disturbances such as the heat exchange 
between the solution and the environment and the solution circulated inside the abdominal cavity and the human 
body. A major advantage of the cascade control structure is that, because of the division into sub-process, the 
resulted control laws are simpler, so more appropriate for an implementation using low cost embedded processors. 
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An important advantage is that the effect of the disturbance is rejected in the inner loop and no longer propagates at 
the output signal. The cascade control structure has a greater insensitivity to disturbances than a classical control 
structure.  
 
Fig. 6. The comparison between the cascade control structure and the feed-forward plus cascade control structure. 
A feed-forward control structure is faster than conventional control structure since it compensates the disturbance 
effect simultaneously with the emergence and propagation of it, thus, the disturbance effect is strongly decreased. 
Future work will be the validation of the proposed HIPEC architecture and control structure by experimental surgery 
that will allow proceeding to certification and production. 
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